Abstract
Purpose of Review
Many women who have a mastectomy will have implant-based breast reconstruction. Long-term complications from breast implant surgery include breast implant illness (BII) and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Here, we review recent literature regarding BII and BIA-ALCL.
Recent Findings
BII is uncommon; however, some patients report systemic symptoms attributed to their implants. Patients with BII may benefit from implant removal without replacement. Current literature does not suggest that complete removal of the implant capsule adds any clinical benefit. Women with textured breast implants have increased risk of developing BIA-ALCL. Treatment consists of complete excision of the implant and capsule. Providers should follow updated NCCN guidelines for systemic therapies and surveillance.
Summary
Women considering breast implants should be properly counseled on potential long-term complications from implant reconstruction. Surgeons should be well informed of the signs and symptoms of breast implant-associated cancers and systemic illness.
Similar content being viewed by others
References
(2022) Aesthetic plastic surgery national databank statistics 2020–2021. In: Aesthetic Surg J. https://doi.org/10.1093/asj/sjac116. Accessed Apr 2024
Atisha DM, Rushing CN, Samsa GP, Locklear TD, Cox CE, Shelley Hwang E, Zenn MR, Pusic AL, Abernethy AP. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015;22:361–9. https://doi.org/10.1245/s10434-014-4246-9.
Atisha D, Alderman AK, Lowery JC, Kuhn LE, Davis J, Wilkins EG. Prospective analysis of long-term psychosocial outcomes in breast reconstruction: two-year postoperative results from the Michigan breast reconstruction outcomes study. Ann Surg. 2008;247:1019–28. https://doi.org/10.1097/SLA.0b013e3181728a5c.
(2020) Breast implants - certain labeling recommendations guidance for industry and food and drug administration staff to improve patient communication. In: U.S. Food and Drug Administration ( FDA). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/breast-implants-certain-labeling-recommendations-improve-patient-communication. Accessed Apr 2024
Bondurant E (1999) Safety of silicone breast implants. In: Institute of Medicine (US) Committee on the safety of silicone breast implants. http://www.nap.edu/catalog/9602. Accessed Apr 2024
Ashar BS. Assessing the risks of breast implants and FDA’s vision for the National Breast Implant Registry. Ann Surg. 2019;269:37–8. https://doi.org/10.1097/SLA.0000000000003052.
Balk EM, Earley A, Avendano EA, Raman G. Long-term health outcomes in women with silicone gel breast implants: a systematic review. Ann Intern Med. 2016;164:164. https://doi.org/10.7326/M15-1169.
Magnusson MR, Cooter RD, Rakhorst H, McGuire PA, Adams WP, Deva AK. Breast implant illness: a way forward. Plast Reconstr Surg. 2019;143:74S-81S. https://doi.org/10.1097/PRS.0000000000005573.
Adidharma W, Latack KR, Colohan SM, Morrison SD, Cederna PS. Breast implant illness: are social media and the internet worrying patients sick? Plast Reconstr Surg. 2020;145:225e–7e. https://doi.org/10.1097/PRS.0000000000006361.
Atiyeh B, Emsieh S. Breast implant illness (BII): real syndrome or a social media phenomenon? A narrative review of the literature. Aesth Plast Surg. 2022;46:43–57. https://doi.org/10.1007/s00266-021-02428-8.
De Vries CEE, Kaur MN, Klassen AF, Sommers K, Hume KM, Pusic AL. Understanding breast implant–associated illness: a Delphi survey defining most frequently associated symptoms. Plast Reconstr Surg. 2022;149:1056e–61e. https://doi.org/10.1097/PRS.0000000000009088.
Cohen Tervaert J, Mohazab N, Redmond D, Van Eeden C, Osman M. Breast implant illness: scientific evidence of its existence. Expert Rev Clin Immunol. 2022;18:15–29. https://doi.org/10.1080/1744666X.2022.2010546.
(2022) Breast implant symptoms. In: Healing breast implant illness. www.healingbreastimplantillness.com/breast-implant-symptoms/. Accessed 10 Apr 2023
Katsnelson JY, Spaniol JR, Buinewicz JC, Ramsey FV, Buinewicz BR. Outcomes of implant removal and capsulectomy for breast implant illness in 248 patients. Plast Recons Surg Global Open. 2021;9: e3813. https://doi.org/10.1097/GOX.0000000000003813.
Bardel A, Wallander M-A, Wedel H, Svärdsudd K. Age-specific symptom prevalence in women 35–64 years old: a population-based study. BMC Public Health. 2009;9:37. https://doi.org/10.1186/1471-2458-9-37.
M Marques, SA Brown, I Oliveira, MNDS Cordeiro, A Morales-Helguera, A Rodrigues, J Amarante, 2010 Long-term follow-up of breast capsule contracture rates in cosmetic and reconstructive cases: plastic and reconstructive surgery 126 769-778 https://doi.org/10.1097/PRS.0b013e3181e5f7bf
McGuire P, Clauw DJ, Hammer J, Haws M, Adams WP. A practical guide to managing patients with systemic symptoms and breast implants. Aesthetic Surg J. 2022;42:397–407. https://doi.org/10.1093/asj/sjab375.
Glicksman C, McGuire P, Kadin M, Lawrence M, Haws M, Newby J, Ferenz S, Sung J, Wixtrom R. Impact of capsulectomy type on post-explantation systemic symptom improvement: findings from the ASERF systemic symptoms in women-biospecimen analysis study: part 1. Aesthetic Surg J. 2022;42:809–19. https://doi.org/10.1093/asj/sjab417.
Keech JA, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Recons Surg. 1997;100(554):555. https://doi.org/10.1097/00006534-199708000-00065.
Clemens MW, Miranda RN. Coming of age: breast implant-associated anaplastic large cell lymphoma after 18 years of investigation. Clin Plast Surg. 2015;42:605–13. https://doi.org/10.1016/j.cps.2015.06.006.
(2023) BIA-ALCL physician resources. In: American Society of Plastic Surgeons. https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources. Accessed 9 Mar 2023
Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, Butler CE, Clemens MW. U.S. Epidemiology of breast implant–associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139:1042–50. https://doi.org/10.1097/PRS.0000000000003282.
(2019) FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market. In: FDA. https://www.fda.gov/news-events/press-announcements/fda-takes-action-protect-patients-risk-certain-textured-breast-implants-requests-allergan. Accessed 17 Aug 2023
McCarthy CM, Roberts J, Mullen E, Loyo-Berrios N, Clemens MW, Yoon SW, Levinson H, Sommers K, Hume K, Carr L. Patient registry and outcomes for breast implants and anaplastic large cell lymphoma etiology and epidemiology (PROFILE): Updated Report 2012–2020. Plast Reconstr Surg. 2023;152:16S-24S. https://doi.org/10.1097/PRS.0000000000010475.
Bizjak M, Selmi C, Praprotnik S, Bruck O, Perricone C, Ehrenfeld M, Shoenfeld Y. Silicone implants and lymphoma: the role of inflammation. J Autoimmun. 2015;65:64–73. https://doi.org/10.1016/j.jaut.2015.08.009.
Jacombs A, Tahir S, Hu H, Deva AK, Almatroudi A, Wessels WLF, Bradshaw DA, Vickery K. In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg. 2014;133:471e–80e. https://doi.org/10.1097/PRS.0000000000000020.
Brody GS, Deapen D, Taylor CR, Pinter-Brown L, House-Lightner SR, Andersen JS, Carlson G, Lechner MG, Epstein AL. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 2015;135:695–705. https://doi.org/10.1097/PRS.0000000000001033.
(2023) T-cell lymphomas. In: NCCN clinical practice guidelines in oncology. https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf. Accessed 9 Oct 2023
Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthetic Surg J. 2019;39:S3–13. https://doi.org/10.1093/asj/sjy331.
Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN. Complete surgical excision is essential for the management of patients with breast implant–associated anaplastic large-cell lymphoma. JCO. 2016;34:160–8. https://doi.org/10.1200/JCO.2015.63.3412.
Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, De Jong D, Fayad LE, Amin MB, Haideri N, Bhagat G, Brooks GS, Shifrin DA, O’Malley DP, Cheah CY, Bacchi CE, Gualco G, Li S, Keech JA, Hochberg EP, Carty MJ, Hanson SE, Mustafa E, Sanchez S, Manning JT, Xu-Monette ZY, Miranda AR, Fox P, Bassett RL, Castillo JJ, Beltran BE, De Boer JP, Chakhachiro Z, Ye D, Clark D, Young KH, Medeiros LJ. Breast implant–associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. JCO. 2014;32:114–20. https://doi.org/10.1200/JCO.2013.52.7911.
(2023) UPDATE: Breast implants: reports of squamous cell carcinoma and various lymphomas in capsule around implants: FDA safetycommunication. In: U.S. Food and Drug Administration (FDA). https://www.fda.gov/medical-devices/safety-communications/update-reports-squamous-cell-carcinoma-scc-capsule-around-breast-implants-fda-safety-communication. Accessed Apr 2024
Fijany AJ, Chaker SC, Hung Y-C, Zago I, Friedlich N, Olsson SE, Montorfano L, Mubang RN, Givechian KB, Boctor MJ, Pekarev M, Martinez-Jorge J, Slater ED (2023) Complication profiles of smooth vs textured tissue expanders in breast reconstruction: a systematic review and meta-analysis. Aesthetic Surg J. sjad319. https://doi.org/10.1093/asj/sjad319
Author information
Authors and Affiliations
Contributions
All authors contributed equally to the preparation and writing of this manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rodriguez-Unda, N.A., McMains, C.J. & Doren, E.L. Long-Term Implications of Implant-Based Breast Reconstruction: What You Should Know About Breast Implant Illness and Breast Implant-Associated ALCL. Curr Breast Cancer Rep (2024). https://doi.org/10.1007/s12609-024-00545-2
Accepted:
Published:
DOI: https://doi.org/10.1007/s12609-024-00545-2